The Orphan Drug Act defines a rare disease as a disease or condition that impacts less than 200,000 people in the United States. Rare diseases are characterized by a wide diversity of symptoms that vary not from one disease to another as well as from patient-to-patient suffering from the same conditions. This diversity adds complexity that Signio is well equipped to help patient and our partners effectively manage. Learn more about Signio’s focus areas and the related therapies on which we focus.